Company Overview
Snapshot
Founded in May 2017 by Omri Nechmadi Naveh, Ronny Barak, and Elad Einav, EndoGI Medical operates with 1–10 employees. The company has raised $54.68K across three funding rounds from two investors. In July 2020, EndoGI Medical received FDA approval for its technology, enabling the simultaneous insertion of two stents into bile ducts.
Business overview
EndoGI Medical is a medical device company focused on developing advanced solutions for gastrointestinal conditions. The company's core technology is a multiple stent placement delivery system designed to treat biliary and pancreatic duct stenosis and strictures caused by various medical issues. This system facilitates the insertion and placement of two or more plastic stents in the common bile or hepatic ducts with a single passage, maintaining guidewire access. EndoGI Medical serves the healthcare industry, specifically targeting hospitals, doctors, and clinics within the gastroenterology and medical devices sectors.
Strategic signal
In July 2020, EndoGI Medical secured FDA approval for its innovative technology, which allows for the simultaneous insertion of two stents into bile ducts. This approval is a significant validation of the company's technology, indicating its potential to reduce patient exposure to infections and other life-threatening complications associated with traditional single-stent insertion methods. This milestone signals strong regulatory acceptance and opens pathways for market entry and clinical use in the United States and Israel, positioning the company for commercial growth.
Log in to access full profile ›Company Intelligence Q&A
- When was EndoGI Medical founded?
- EndoGI Medical was founded in May 2017.
- What is EndoGI Medical's core product?
- EndoGI Medical develops a multiple stent placement delivery system for treating biliary and pancreatic duct stenosis and strictures, enabling the insertion of two or more plastic stents with one passage.
- Has EndoGI Medical received any regulatory approvals?
- In July 2020, EndoGI Medical received FDA approval for its technology, which allows for the simultaneous insertion of two stents into the bile ducts.
- Which investors have participated in EndoGI Medical's funding rounds?
- In August 2022, EndoGI Medical received funding from NGT HealthCare II. In April 2019, NGT3 also participated in a funding round.
- Has EndoGI Medical received any grants?
- In December 2019, EndoGI Medical received a grant from EU Horizon 2020.